Blood-Brain Barrier (BBB) Market Trend, and Forecast Research Report by 2027

The latest market evaluation report on the Blood-Brain Barrier (BBB) market explores how the Blood-Brain Barrier (BBB) market will continue to expand for the forecast period 2020 – 2027. The study further serves as a unique research for stakeholders, product owners, and field marketing executives looking for actionable data and unique resource on market size, share, and growth. The market intelligence report gives business evangelists an authority to review the major trends, opportunities, and challenges expected to shape the future of the industry during the estimated period. Importantly, the study not only helps spot the major vendors but also their winning strategies

Key players operating in the market are Allon Therapeutics, Inc., Angiochem Inc., Armagen Technologies, Inc., Bristol-Myers Squibb, BiOasis Technologies, Inc., Sanofi Genzyme, CarThera, Cephalon Inc., Nanomerics, and F. Hoffman La-Roche AG.

Major prevalence of neurological disorders and rapidly increasing geriatric population are key factors driving growth of the global blood-brain barrier market.In January 2021, Nanoform Finland signed an agreement with Herantis Pharma. This agreement will help both companies to improve blood-brain-barrier penetration in nasal drug delivery routes for Parkinson’s therapies using nanoparticle technology.

Get a sample of the report : https://www.emergenresearch.com/request-sample/633

Major factors driving market revenue growth include major prevalence of neurological disorders such as Parkinson’s Disease, Alzheimer’s Disease, Hunter’s Syndrome, and brain tumors.This function also significantly impedes delivery of drugs to the brain. In case of central nervous system disorders, it is required to deliver drugs across this barrier and provide the appropriate therapeutic effect to the targeted location.Ongoing technological developments in magnetic resonance imaging technology that helps to identify blood-brain barrier and introduction of advanced nanotechnology and ultrasound applications is expected to drive market revenue growth going ahead.

Parkinson’s disease segment accounted for major revenue share in global market in 2020 and is expected to register a 25.1% CAGR throughout the forecast period. This is attributed to major prevalence of Parkinson’s Disease among an expanding global patient pool.

Asia Pacific is expected to register the fastest revenue CAGR throughout the forecast period, which can be attributed to rapid advancements in pharmaceutical and healthcare infrastructure, increasing aging population, major prevalence of neurological disorders, increasing number of hospitals and long-term care facilities in countries across the globe.

Request a discount on the report : https://www.emergenresearch.com/request-discount/633

For the purpose of this report, Emergen Research has segmented the global blood-brain barrier (BBB) market based on application, technology, end-use, and by region:

Application Outlook (Revenue, USD Billion; 2018–2028)

• Alzheimer’s Disease
• Epilepsy
• Parkinson’s Disease
• Multiple Sclerosis
• Hunter’s Syndrome
• Brain Cancer

Technology Outlook (Revenue, USD Billion; 2018–2028)

• Bispecific Antibody RMT Approach
• Trojan Horse Approach
• Increasing Permeability
• Passive Diffusion
• Others

End-Use Outlook (Revenue, USD Billion; 2018–2028)

• Hospitals
• Surgical centers
• Research Institutes
• Others

Regional Outlook (Revenue: USD Billion; 2018–2028)

• North America
  1. U.S.
  2. Canada
  3. Mexico
• Europe
  1. Germany
  2. France
  3. U.K.
  4. BENELUX
  5. Italy
  6. Spain
  7. Switzerland
  8. Russia
  9. Rest of Europe
• Asia Pacific
  1. China
  2. Japan
  3. South Korea
  4. India
  5. Rest of APAC
• Latin America
  1. Brazil
  2. Rest of LATAM
• Middle East & Africa
  1. Saudi Arabia
  2. UAE
  3. South Africa
  4. Turkey
  5. Rest of MEA

To define, describe, and forecast the market by product type, market, and key regions.

Key points discussed in the report for Global Blood-Brain Barrier (BBB) Market:

Chapter 1: Introduction, market driving force product, Objectives of the Study, and Research Scope of the Blood-Brain Barrier (BBB) market

Chapter 2: Exclusive Summary –vital information of the Blood-Brain Barrier (BBB) Market.

Chapter 3: Market Dynamics- Drivers, Trends, and Challenges of the Blood-Brain Barrier (BBB) Market

Chapter 4: Blood-Brain Barrier (BBB) Market Factor Analysis Porters Five Forces, Supply/Value Chain, PESTEL analysis, Market Entropy, Patent/Trademark Analysis.

Chapter 5: Market segmentation by Type, End-User and Region 2016-2018

Chapter 6: Analysis of the market by segments, by countries and by manufacturers with revenue share and sales by key countries in these various regions.

Chapter 7 & 8: Appendix, Methodology and Data Source…Continued

Finally, Blood-Brain Barrier (BBB) Market is a valuable source of guidance for individuals and companies.

Read More: https://www.emergenresearch.com/industry-report/blood-brain-barrier-market

Related Reports:

About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Facebook | LinkdIn | Twitter | Blogs